Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ipsen

Market Cap 1.3TCr 1.5TCr 1.19TCr 1.12TCr 2.09TCr 1,42600Cr 2.13TCr 14TCr 5.5TCr 69TCr 5.63TCr 5.51TCr 2,40300Cr P/E Ratio 2026 *
14.6x
P/E Ratio 2027 * 14.2x
Enterprise Value 1.16TCr 1.34TCr 1.07TCr 1TCr 1.87TCr 1,27600Cr 1.9TCr 13TCr 4.92TCr 62TCr 5.04TCr 4.93TCr 2,15000Cr EV / Sales 2026 *
2.73x
EV / Sales 2027 * 2.4x
Free-Float
40.65%
Yield 2026 *
0.91%
Yield 2027 * 0.95%
1 day-0.51%
1 week-0.51%
Current month+0.26%
1 month-5.42%
3 months+2.21%
6 months+28.27%
Current year+31.93%
1 week 152.7
Extreme 152.7
159.2
1 month 148.7
Extreme 148.7
164.2
Current year 116
Extreme 116
173.5
1 year 100.2
Extreme 100.2
173.5
3 years 87.95
Extreme 87.95
173.5
5 years 77
Extreme 77
173.5
10 years 34.2
Extreme 34.2
173.5
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Date Insider Type Main position Quantity % Market Cap.
01/06Fiscal year

Chief Executive Officer

-26,583 0.0317%
27/05Sell

Chief Executive Officer

-1,000 0.0012%
25/02Sell

Chairman

3,800 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%-0.51%+51.25%+41.57% 1.5TCr
-2.41%+0.14%+38.28%+153.06% 1,01000Cr
+1.07%+3.48%+53.32%+49.09% 58TCr
+1.32%+0.22%+19.18%+67.17% 40TCr
-0.34%0.00%+21.28%+19.14% 33TCr
-0.19%+3.87%+26.47%+34.87% 28TCr
-1.00%-3.22%+23.42%+14.26% 28TCr
-0.94%+4.21%-43.09%-48.67% 20TCr
+0.32%+1.61%+20.32%+59.80% 19TCr
-0.22%-2.76%+14.19%+61.12% 16TCr
Average -0.28%+0.76%+22.46%+45.14% 34.44TCr
Weighted average by Cap. -0.54%+1.03%+28.09%+70.35%

Financials

2026 *2027 *
Net sales 425.35Cr 492.48Cr 391.96Cr 366.9Cr 687.59Cr 47TCr 698.23Cr 4.63TCr 1.8TCr 23TCr 1.85TCr 1.81TCr 79TCr 441.15Cr 510.77Cr 406.52Cr 380.53Cr 713.13Cr 49TCr 724.17Cr 4.8TCr 1.87TCr 24TCr 1.92TCr 1.88TCr 82TCr
Net income 92Cr 106.87Cr 85Cr 80Cr 149.21Cr 10TCr 151.52Cr 1TCr 391.59Cr 4.94TCr 401.09Cr 392.55Cr 17TCr 92Cr 106Cr 84Cr 79Cr 148Cr 10TCr 150.29Cr 996.2Cr 388.41Cr 4.9TCr 397.83Cr 389.36Cr 17TCr
Net Debt -136.19Cr -157.68Cr -125.5Cr -117.47Cr -220.15Cr -15TCr -223.56Cr -1.48TCr -577.77Cr -7.3TCr -591.79Cr -579.19Cr -25TCr -237.18Cr -274.61Cr -218.56Cr -204.58Cr -383.4Cr -26TCr -389.34Cr -2.58TCr -1.01TCr -13TCr -1.03TCr -1.01TCr -44TCr
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
15/26/15 157.00 -0.51% 11,761
12/26/12 157.80 +0.45% 68,924
11/26/11 157.10 +1.29% 1,43,949
10/26/10 155.10 -1.77% 1,29,360
09/26/09 157.90 +0.06% 1,13,067
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
157.80EUR
Average target price
159.25EUR
Spread / Average Target
+0.92%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!